Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
about
C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancerBreaking boundaries-coagulation and fibrinolysis at the neurovascular interfaceThe significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosisFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapyBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeThe blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targetingExpression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1)Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitisCerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrierIn vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticityMagnetic brain stimulation upregulates adhesion and prevents Eae: MMP-2, ICAM-1, and VCAM-1 in the choroid plexus as a targetComplementary and alternative medicine for the treatment of multiple sclerosisMatrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory.Minimal peptide length requirements for CD4(+) T cell clones--implications for molecular mimicry and T cell survival.Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy.Hyperbaric oxygen therapy for traumatic brain injuryThe extracellular matrix in multiple sclerosis: an update.Stem cells for spinal cord regeneration: Current statusT-cell production of matrix metalloproteinases and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain.Nervous system pathology: the fibrin perspective.Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage.Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?Matrix metalloproteinases and neuroinflammation in multiple sclerosis.Matrix metalloproteinase-9 in lung remodeling.Cannabinoids and neuroinflammation.tPA receptors and the fibrinolytic response in multiple sclerosis lesions.A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitisElevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage.Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.Myelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis ratDevelopment of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease.Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters.The autolytic regulation of human kallikrein-related peptidase 6.Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axisCD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-kappaB (NFkappaB) and activator protein-1 (AP-1)Brain extracellular matrix in neurodegeneration.Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.Complement in multiple sclerosis: its role in disease and potential as a biomarker.
P2860
Q24803584-09C57919-AE4A-488C-8CF7-7CA20BB95424Q26781646-E43E7ADA-0568-4FEE-884D-C8B0A1BD4EE3Q27009126-43AB6C86-BF56-44CB-9784-4290956C7516Q27011473-BD33A74A-7EB0-46F0-9C04-F89D4177B28DQ28288148-6F2ACB45-D255-4549-B8C0-4302D653301FQ28299076-ACFF851A-0500-4EB5-8611-BEDD3536E532Q28362973-118BA753-795B-4FAD-B966-C82F4EE5607BQ28505308-148F5F5C-A51B-4AD0-A7B9-43DFCC1CC186Q28510213-49989B35-6CB6-41C1-98A5-8C562649BDF0Q28570628-93D09FA9-9FDE-45C6-8FA1-8DF6CB0A89B1Q28577049-79CBEC55-1FCB-4993-8BD1-C32EEE7EDB27Q29031018-FC8DDB6A-D81E-48B0-9865-11C55874D24EQ30650111-B935988F-D52A-4F76-B3E5-4BBB51F1E9FDQ30843475-10BFC8EA-A2DA-4BCB-B4F1-3ECE18406DD5Q32001558-D31BA97C-9EAB-4ED5-A6D6-CE5069B2445EQ33452711-299D12D4-DAC8-49DF-8317-36C8DEE4B34DQ34232680-583A1370-C9E5-4557-9BF7-AD5021784176Q34482689-AA0CA42F-DB5A-49D4-B937-F0545FE0EF12Q34509768-003F3691-CBF3-4402-9039-1708E7E5A8AAQ34584793-DCC0B95B-D341-496D-8610-C07E0143175AQ34652720-AAADC96F-41F5-47BF-8727-E3730FD87181Q34768858-E2B29CD2-BB20-4168-8ADD-12AC9ED4A85FQ35017633-2AD397DE-0FE7-4383-932B-17C2679968A1Q35032152-A9ECEB7C-8C16-4F76-8461-CF352FD68502Q35046205-58639FB1-0672-4208-A5B0-C4BFB8A55C54Q35083789-4957C39F-A1F8-47FB-ABB1-649AE652C846Q35085079-B1C0D98B-7912-43DA-8A56-1B61F1D704F4Q35608589-2A7DC0E0-71CB-4E6F-8733-F05B5A448EE6Q35747177-8CA0016A-3584-4B2C-BC9C-BE93E664A409Q35842235-D2BDBAB3-3100-4B6D-A6F4-EE5A1F722FDFQ36246370-D7BBF12F-254E-4832-8C53-28A578C1BB36Q36327527-1701679A-CF35-4790-B85F-7BB76D92DE19Q36700657-BB02689B-0A24-4FEE-AAD0-6A28A7157380Q36788997-0B314649-198F-4600-BF48-4CF2ECFAE29CQ36840687-3AEB296C-4214-486A-A08C-73968FF58897Q36962704-485E3FA2-4A81-4211-B87C-7C4301D30A3FQ37091615-6DA2C58E-374D-410E-9C28-88DF23C1A56CQ37228777-2A676CAF-0BD7-4CD7-A575-BA90C5126545Q37297572-572DA8D0-403E-42DE-A25B-9088BD94362CQ37336914-81AC56F9-CEA9-4265-9E99-BFC4DAD1F133
P2860
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Plasminogen activators and mat ...... of the central nervous system.
@ast
Plasminogen activators and mat ...... of the central nervous system.
@en
type
label
Plasminogen activators and mat ...... of the central nervous system.
@ast
Plasminogen activators and mat ...... of the central nervous system.
@en
prefLabel
Plasminogen activators and mat ...... of the central nervous system.
@ast
Plasminogen activators and mat ...... of the central nervous system.
@en
P1476
Plasminogen activators and mat ...... of the central nervous system
@en
P2093
M L Cuzner
P356
10.1016/S0165-5728(98)00241-0
P577
1999-02-01T00:00:00Z